FGF21 promotes wound healing of rat brain microvascular endothelial cells through facilitating TNF-α-mediated VEGFA and ERK1/2 signaling pathway

血管生成 信号转导 血管内皮生长因子 血管内皮生长因子A 伤口愈合 医学 化学 血管内皮生长因子受体 细胞生物学 肿瘤坏死因子α 癌症研究 生物 免疫学
作者
Weiting Chen,Zhongen Shen,Shuiqi Cai,Long Chen,Da-Bin Wang
出处
期刊:Advances in Clinical and Experimental Medicine [Wroclaw Medical University]
卷期号:30 (7): 711-720 被引量:2
标识
DOI:10.17219/acem/133494
摘要

Background Wound healing is an essential physiological process in recovery after microsurgery. Objectives To further understand the functions of fibroblast growth factor 21 (FGF21), the roles of this factor were examined and its correlations with inflammation, vascular endothelial growth factor A (VEGFA) and ERK1/2 signaling pathway activation were analyzed. Material and methods Rat brain microvascular endothelial cells (RBMECs) were treated with interleukin (IL)-1β and used for the experiments. Cell Counting Kit-8 (CCK-8) was used to detect the cell viability of RBMECs after treatment with IL-1β (1 ng/mL) and FGF21 or VEGFA overexpression, while changes in apoptosis were measured through flow cytometry. Migration was checked through the scratch test. FGF21 and VEGFA RNA expression was assessed using reverse-transcription quantitative polymerase chain reaction (RT-qPCR), which was also used to examine RNA expression of Bcl-2, Bax and caspase-3. After IL-1β treatment and FGF21 overexpression, tumor necrosis factor alpha (TNF-α) and tumor growth factor β1 (TGF-β1) proteins level were observed with enzyme-linked immunosorbent assay (ELISA), which was also applied to check the expression of ERK1/2 after overexpression of FGF21 and VEGFA. PD98059 (50 μM), an ERK1/2 inhibitor, was used to examine the roles of ERK1/2 in regulating cell viability and apoptosis. Results The IL-1β treatment significantly decreased the viability of RBMECs and TGF-β1, but promoted cell apoptosis and TNF-α expression. FGF21 was downregulated by IL-1β treatment but its overexpression enhanced the viability of RBMECs and TGF-β1 and ERK1/2 protein levels, and attenuated cell apoptosis and TNF-α. Upregulated TNF-α restrained cell viability and apoptosis of RBMECs after FGF21 overexpression, and its upregulation not only suppressed FGF21, but also VEGFA. Moreover, VEGFA suppression by TNF-α increased cell viability and ERK1/2 protein levels, and suppressed the apoptosis of RBMECs through its upregulation. However, PD98059 obstructed the functions of FGF21 and VEGFA. Conclusions FGF21 promoted the cell viability of RBMECs through upregulating TNF-α-mediated VEGFA and ERK1/2 signaling.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
氨基钠发布了新的文献求助10
1秒前
王欣雪完成签到,获得积分20
2秒前
jay发布了新的文献求助10
2秒前
专注语堂完成签到,获得积分10
3秒前
1234发布了新的文献求助10
3秒前
谢诚杰完成签到,获得积分10
3秒前
6秒前
颜路完成签到,获得积分20
7秒前
彭于晏应助无敌鱼采纳,获得10
7秒前
8秒前
互助遵法尚德应助贺贺采纳,获得10
8秒前
JJ发布了新的文献求助10
10秒前
ss关闭了ss文献求助
11秒前
12秒前
傲娇的凛发布了新的文献求助10
13秒前
疯狂的绮波完成签到,获得积分10
14秒前
cxy发布了新的文献求助20
15秒前
16秒前
AST完成签到,获得积分10
16秒前
酸海椒发布了新的文献求助10
16秒前
17秒前
万能图书馆应助1234采纳,获得10
17秒前
传奇3应助佳佳采纳,获得10
18秒前
深情安青应助氨基钠采纳,获得10
18秒前
19秒前
传奇3应助南栀采纳,获得10
19秒前
19秒前
李哈哈应助jay采纳,获得10
19秒前
科研通AI2S应助六千里大风采纳,获得10
20秒前
跳跃的八宝粥完成签到,获得积分10
20秒前
傲娇的凛完成签到,获得积分10
20秒前
活泼菠萝发布了新的文献求助10
21秒前
HIy发布了新的文献求助10
21秒前
li完成签到,获得积分10
22秒前
酸海椒完成签到,获得积分10
22秒前
23秒前
周子强发布了新的文献求助10
26秒前
天天快乐应助明理的千风采纳,获得10
26秒前
Lucas应助体贴的嵩采纳,获得10
27秒前
27秒前
高分求助中
One Man Talking: Selected Essays of Shao Xunmei, 1929–1939 1000
The Illustrated History of Gymnastics 800
Yuwu Song, Biographical Dictionary of the People's Republic of China 800
Herman Melville: A Biography (Volume 1, 1819-1851) 600
Division and square root. Digit-recurrence algorithms and implementations 500
Hemerologies of Assyrian and Babylonian Scholars 500
Manual of Clinical Microbiology, 13th Edition 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 有机化学 工程类 生物化学 纳米技术 物理 内科学 计算机科学 化学工程 复合材料 遗传学 基因 物理化学 催化作用 电极 光电子学 量子力学
热门帖子
关注 科研通微信公众号,转发送积分 2499529
求助须知:如何正确求助?哪些是违规求助? 2154894
关于积分的说明 5511980
捐赠科研通 1875637
什么是DOI,文献DOI怎么找? 932748
版权声明 563762
科研通“疑难数据库(出版商)”最低求助积分说明 498483